| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0074-4014-12 | 0074-4014 | HUMAN PRESCRIPTION DRUG | Kaletra | Lopinavir and Ritonavir | TABLET, FILM COATED | ORAL | 20240215 | N/A | NDA | NDA021906 | AbbVie Inc. | LOPINAVIR; RITONAVIR | 200 mg/1; 50 mg/1 | 120 TABLET, FILM COATED in 1 BOTTLE (0074-4014-12) |
| 0074-0522-60 | 0074-0522 | HUMAN PRESCRIPTION DRUG | Kaletra | Lopinavir and Ritonavir | TABLET, FILM COATED | ORAL | 20100618 | N/A | NDA | NDA021906 | AbbVie Inc. | LOPINAVIR; RITONAVIR | 100 mg/1; 25 mg/1 | 60 TABLET, FILM COATED in 1 BOTTLE (0074-0522-60) |
| 0074-6799-22 | 0074-6799 | HUMAN PRESCRIPTION DRUG | Kaletra | Lopinavir and Ritonavir | TABLET, FILM COATED | ORAL | 20100618 | N/A | NDA | NDA021906 | AbbVie Inc. | LOPINAVIR; RITONAVIR | 200 mg/1; 50 mg/1 | 120 TABLET, FILM COATED in 1 BOTTLE (0074-6799-22) |
| 0074-3008-60 | 0074-3008 | HUMAN PRESCRIPTION DRUG | Kaletra | Lopinavir and Ritonavir | TABLET, FILM COATED | ORAL | 20240614 | N/A | NDA | NDA021906 | AbbVie Inc. | LOPINAVIR; RITONAVIR | 100 mg/1; 25 mg/1 | 60 TABLET, FILM COATED in 1 BOTTLE (0074-3008-60) |